United Capital Financial Advisors LLC Takes Position in Astera Labs, Inc. $ALAB

United Capital Financial Advisors LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,893 shares of the company’s stock, valued at approximately $1,397,000.

A number of other institutional investors and hedge funds have also made changes to their positions in ALAB. Reflection Asset Management acquired a new position in Astera Labs in the 4th quarter valued at about $25,000. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs during the 2nd quarter worth approximately $25,000. Smartleaf Asset Management LLC grew its stake in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in shares of Astera Labs in the 4th quarter valued at approximately $33,000. Finally, Whipplewood Advisors LLC increased its holdings in shares of Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Down 4.8%

NASDAQ:ALAB opened at $289.47 on Friday. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The stock has a market cap of $50.22 billion, a PE ratio of 143.30 and a beta of 3.84. The firm’s fifty day simple moving average is $342.38 and its 200-day simple moving average is $249.65.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Manuel Alba sold 136,974 shares of Astera Labs stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the transaction, the director directly owned 1,287,524 shares in the company, valued at $569,098,483.24. The trade was a 9.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities research analysts recently weighed in on ALAB shares. Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Bank of America boosted their price target on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Stifel Nicolaus increased their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Jefferies Financial Group lifted their price objective on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Finally, Citigroup reiterated a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $340.53.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.